Bekanamycin

CAS No. 4696-76-8

Bekanamycin( Kanamycin B )

Catalog No. M21416 CAS No. 4696-76-8

Bekanamycin is an aminoglycoside antibiotic.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 26 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Bekanamycin
  • Note
    Research use only, not for human use.
  • Brief Description
    Bekanamycin is an aminoglycoside antibiotic.
  • Description
    Bekanamycin is an aminoglycoside antibiotic.(In Vitro):Bekanamycin (Kanamycin B) is a precursor for semisynthetic antibiotics such as Arbekacin and Dibekacin and is generally extracted from the broth of S. kanamyceticus.Bekanamycin (Kanamycin B) in a concentration-dependent fashion reduces reversibly the quantal content of the end-plate potentials while it has no observable effect on the configuration of the extracellularly recorded presynaptic action potential. The reduction in evoked transmitter release produced by Bekanamycin could be antagonized either by increasing the external calcium concentration or by drugs like the aminopyridines which are to greatly enhance transmitter release from motor nerve terminals. Bekanamycin exerts potent inhibitory effects on transmitter release probably by interfering with the influx of calcium that occurs during depolarization of motor nerve terminals.
  • In Vitro
    Bekanamycin (Kanamycin B) is a precursor for semisynthetic antibiotics such as Arbekacin and Dibekacin and is generally extracted from the broth of S. kanamyceticus.Bekanamycin (Kanamycin B) in a concentration-dependent fashion reduces reversibly the quantal content of the end-plate potentials while it has no observable effect on the configuration of the extracellularly recorded presynaptic action potential. The reduction in evoked transmitter release produced by Bekanamycin could be antagonized either by increasing the external calcium concentration or by drugs like the aminopyridines which are to greatly enhance transmitter release from motor nerve terminals. Bekanamycin exerts potent inhibitory effects on transmitter release probably by interfering with the influx of calcium that occurs during depolarization of motor nerve terminals.
  • In Vivo
    ——
  • Synonyms
    Kanamycin B
  • Pathway
    Microbiology/Virology
  • Target
    Antibiotic
  • Recptor
    Antibiotic
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4696-76-8
  • Formula Weight
    483.51
  • Molecular Formula
    C18H37N5O10
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:100 mg/mL (206.82 mM);DMSO:1 mg/mL (2.07 mM; ultrasonic and warming and heat to 80°C)
  • SMILES
    C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)N)N
  • Chemical Name
    (2R3S4R5R6R)-5-amino-2-(aminomethyl)-6-(((1R2S3S4R6S)-46-diamino-3-(((2S3R4S5S6R)-4-amino-35-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)tetrahydro-2H-pyran-34-diol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Morales MA et al. Effects of bekanamycin and dibekacin on the electrical activity of cardiac pacemaker cells. Arch Med Res. 1993 Winter;24(4):339-45.
molnova catalog
related products
  • 8-Azaguanosine

    8-Azaguanosine, a purine nucleoside analog, exhibits a broad spectrum of antitumor activity and is employed in the study of various tumor diseases.

  • 2′-C-Methyl-6-O-meth...

    2′-C-Methyl-6-O-methylinosine (2′-C-Methyl-6-O-methylinosine) is a hypoxanthine analog exhibiting diverse physical activities for researching various tumor diseases.

  • BMS626529

    BMS-626529 is a novel attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells.